Sökresultat

In a recent publication, Professor Mats Ohlin of the Department of Immunotechnology and Dr. Ayelet Peres (Yale University) discuss naming of immunoglobulin and T cell receptor genes, and underscore the need for a non-positional naming structure. Naming of immunoglobulin and T cell receptor genes is currently based on their perceived relative location in the genome. This principle is very attractiv

https://www.immun.lth.se/article/towards-relevant-naming-schemes-t-cell-receptor-and-immunoglobulin-germline-genes - 2026-07-11

Prof. Mats Ohlin, Prof. Malin Lindstedt and Ass. Prof. Anna Gerdtsson obtained in total 16 mil SEK for their research projects by the Swedish Research Council and Swedish Cancer Society and VR in 2025. In 2025, we celebrate the enormous success of 3 researchers at the Department of Immunotechnoloy who managed to secure a large amount of funding for their research groups.Funded projectsProfessor Ma

https://www.immun.lth.se/article/researchers-department-immunotechnology-attract-key-project-grants-2025 - 2026-07-11

A research team headed by Professor Carl Borrebaeck of the Department of Immunotechnology in collaboration with research teams at the Faculty of Medicine (Lund University), the Swiss Cancer Center, and EPFL in Lausanne has received a donation of SEK 420 million from the Mrs Berta Kamprad's foundation to promote research in the field of immuno-oncology. Full article: SEK 420 million to cancer resea

https://www.immun.lth.se/article/major-donation-research-team-headed-professor-carl-borrebaeck-department-immunotechnology - 2026-07-11

Dr Peter Ellmark brings valuable expertise from biotech industry and his activities at the Department of Immunotechnology will strengthen the education and research fields within immuno-oncology. Peter Ellmark is Chief Scientific Officer at Alligator Bioscience, Lund, and he has more than 20 years’ experience of developing antibodies for immunotherapy of cancer. He holds a PhD and an Associate Pro

https://www.immun.lth.se/article/peter-ellmark-joins-department-immunotechnology-adjunct-professor - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. Approximately 10–15 per cent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovered a way to treat these aggressive tumours through manipulation of t

https://www.tcr.lu.se/article/new-treatment-aggressive-breast-cancer - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. Six LU researchers receive ERC Starting Grants Colourful common wall lizards, an innovative X-ray microscope and advanced research on Alzheimer’s, leukaemia, photographic evidence and the origin of life. Six researchers from Lund University in Sweden have been granted five-year starting grants totalling EUR 9.5 millio

https://www.tcr.lu.se/article/pi-emma-hammarlund-receives-erc-grant - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 800 children in the US are diagnosed with neuroblastoma, an aggressi

https://www.tcr.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. Emma Hammarlund and Sofie Mohlin at TCR, together with two colleagues from Oxford University, have reviewed how oxygen-sensing mechanisms across eukaryotic kingdoms are alike. From a functional perspective, these systems are active at low oxygen and degraded at high, although their scope varies.    2020-11-16_hammarlu

https://www.tcr.lu.se/article/oxygen-sensing-mechanisms-across-eukaryotic-kingdoms-and-their-roles-complex-multicellularity - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated.  Big congratulations to PI:s Daniel Bexell Novel treatment for high-risk neuroblastoma, Christer Larsson Mechanisms determining breast cancer cell fate upon death receptor stimulation - apoptosis or a change in phenotype, Ramin Massoumi Targeted therapy against metastatic melanoma and Sofie Mohlin An Embryonic Model i

https://www.tcr.lu.se/article/pis-tcr-receive-cancerfonden-grants - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. SAVE THE DATE for this upcoming event. Dear all, We hope you are all keeping yourselves safe and healthy through this challenging time.We would like to cordially invite you to a digital imaging meeting including short presentations and discussions about existing imaging facilities and the need for development of the i

https://www.tcr.lu.se/article/coming-lucc-imaging-nuclear-medicineradiology-seminar - 2026-07-11

Big congratulations to PI:s Håkan Axelson Transformation of renal epithelial cells: the nephron and renal cell carcinoma, Anders Bjartell Integration of Biomarkers in Clinical Models for Improved Outcome Prediction and New Therapies in Prostate Cancer, Emma Hammarlund Utilizing the isotopic elemental fingerprint of cancer to understand tumorgenesis and for the development of truly non-invasive dia

https://www.tcr.lu.se/article/pis-tcr-receive-cancerfonden-grants-0 - 2026-07-11

Big congratulations to Alexander Pietras group on receiving ERC grant. Tumor recurrence and therapeutic resistance: exploring and exploiting the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors.  

https://www.tcr.lu.se/article/alexander-pietras-group-receives-erc-grant - 2026-07-11

Big congratulations to: Alexander Pietras, The irradiated brain tumor microenvironment: Biology and therapeutic tagets, on receiving Senior Investigator Award, and to Paulina Bolivar, in Kristian Pietras group, Integrative single-cell and spatial analyses to reveal micriniche organization in the tumor microenvironment of triple negative breast cancer, on receiving Postdoc grant from Cancerfonden.

https://www.tcr.lu.se/article/new-cancerfonden-grants - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. PI Daniel Bexell has been awarded millions in funding from Åke Wibergs foundation that goes to young PIs in medical research. One of the aims is to find out why some tumors develop resistance to today’s treatment but also to find new treatment strategies. Every year around 20 children in Sweden are diagnosed with Neur

https://www.tcr.lu.se/article/millions-funding-pi-daniel-bexell - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. The platelet-derived growth factor (PDGF) signalling pathway is often dysregulated in cancer and PDGF-receptor expression has been linked to unfavourable prognostic factors in breast cancer (e.g. ER negativity, high Ki67 and high grade). This study aimed to evaluate the expression of PDGFRα, PDGFRβ and ligand PDGF-CC

https://www.tcr.lu.se/article/pdgf-pathway-breast-cancer-linked-tumour-aggressiveness-triple-negative-subtype-and-early-recurrence - 2026-07-11

Congratulations to Yvonne Ceders group and to Alexander Pietras group on receiving Cancerfonden grants.

https://www.tcr.lu.se/article/researchers-tcr-receives-cancerfonden-grants - 2026-07-11

Big congratulations to Göran B Jönssons group (Oncology), Kristian Pietras group and Joan Yuans group (Developmental Immunology) on receiving a joint grant from Knut and Alice Wallenbergs Foundation (KAW).   Article about the project via this link (in Swedish).

https://www.tcr.lu.se/article/researcher-tcr-receives-kaw-grant - 2026-07-11

Big congratulations to  Kazi Uddins group on receiving Barncancerfonden grant for "Utveckling av riktade kombinationsterapi och nya verktyg för att förutspå terapi-resistens" and to Alexander Pietras group on receiving Barncancerfonden grant for "Syrebristberoende måltavlor i barngliom och ponsgliom".

https://www.tcr.lu.se/article/researchers-tcr-receive-barncancerfonden-grants - 2026-07-11

Big congratulations on receiving grants from Swedish Research Council (Vetenskapsrådet, VR):Daniel Bexell, Mekanismer och nya behandlingsstrategier mot resistent neuroblastom, and to...Anders Bjartell, Målriktade behandlingar och biomarkörer vid avancerad prostatacancer, and to...Kristian Pietras, Definiering av funktionella cell-nischer i tumörens mikromiljö som mål för precisionsmedicin.

https://www.tcr.lu.se/article/researchers-tcr-receive-swedish-research-council-grants - 2026-07-11

Big congratulations on receiving Cancerfonden grants:Daniel Bexell, Decoding and Targeting Treatment-Resistant Metastatic Neuroblastoma, an to...Christer Larsson, Induction and consequences of interferon expression in breast cancer cells, and to...Ramin Massoumi, Novel preclinical models for treatment of lung cancer. 

https://www.tcr.lu.se/article/researchers-tcr-receive-cancerfonden-grants - 2026-07-11